Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 1:23 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 265–288 of 2,674 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: Stanford University Clear all

Conditions: Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer
Interventions: Talazoparib Tosylate; Drug
Lead sponsor: Melinda Telli; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Stanford, California

Conditions: Non-Hodgkin Lymphoma, Large B-cell Lymphoma
Interventions: Axicabtagene Ciloleucel; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2038
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: OCD
Interventions: Psychotherapy, Pharmacotherapy; Behavioral · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Substance Withdrawal Syndrome
Interventions: Ondansetron and Placebo crossover; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Stanford, California

Conditions: Eating Disorders, Binge Eating Disorder, Bulimia Nervosa
Interventions: Recovery Record adaptive smartphone application, Recovery Record standard smartphone application; Behavioral
Lead sponsor: Recovery Record Research; Industry
Eligibility: 16 Years and older
Enrollment: 3,340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 2
States / cities: San Francisco, California • Stanford, California

Conditions: Autism Spectrum Disorder
Interventions: Social Initiation Motivation Intervention; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 4 Years to 6 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Stanford, California

Conditions: Chronic Wounds
Interventions: Autologous Regenerative Technology (ART); Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Redwood City, California

Conditions: Obsessive-Compulsive Disorder
Interventions: Stereoencephalography (SEEG), Deep Brain Stimulation (DBS); Device
Lead sponsor: Casey H. Halpern, M.D.; Other
Eligibility: 22 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 2
States / cities: Stanford, California • Philadelphia, Pennsylvania

Conditions: Pain
Interventions: Alfentanil, Saline placebo infusion; Drug · Other
Lead sponsor: Martin Angst; Other
Eligibility: 18 Years to 70 Years
Enrollment: 242 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Stanford, California

Conditions: Multiple Myeloma
Interventions: high dose chemotherapy then autologous hematopoietic cell transplant; Procedure
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1994 – 2010
U.S. locations: 1
States / cities: Stanford, California

Conditions: Physical Health
Interventions: Virtual Reality Physical Therapy, Traditional Physical Therapy; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 7 Years to 25 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Arthritis, Rheumatoid
Interventions: Apremilast, Placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Stanford, California

Conditions: Cannabis Use
Interventions: Stanford Smart Talk Cannabis Awareness and Prevention curriculum; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 10 Years to 20 Years
Enrollment: 658 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Pulmonary Arterial Hypertension (PAH)
Interventions: Tiprelestat (5 mg), Placebo (1 mL 0.9% saline solution), Tiprelestat (10 mg); Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 10
States / cities: Tucson, Arizona • San Francisco, California • Stanford, California + 7 more

Conditions: Schizophrenia
Interventions: [11C]UCB-J radiotracer, PET-MR; Drug · Device
Lead sponsor: Davidzon, Guido, M.D.; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 2
States / cities: Palo Alto, California • Stanford, California

Conditions: Pregnancy Complications
Interventions: Dexcom Seven Plus Continuous Glucose Monitoring System; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Stanford, California

Conditions: Lymphoma, Non-Hodgkin's Lymphoma
Interventions: Rituximab; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Stanford, California

Conditions: Brain Activity Related to Opioid Administration, Brain Activity Related to Drug Liking
Interventions: Observational study in patients receiving fentanyl for surgery; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Head and Neck Cancer, Carcinoma, Squamous Cell, Head and Neck Cancers
Interventions: Lapatinib, Radiotherapy (radiation), G.E. Healthcare 1.5T MR, systems revision 12.0 M5, DCE-MRI; Drug · Procedure · Device
Lead sponsor: Quynh-Thu Le; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2016
U.S. locations: 5
States / cities: Stanford, California • Gainsville, Florida • New York, New York + 2 more

Conditions: Insulin Resistance, Hypertriglyceridemia
Interventions: Rosiglitazone, Fenofibrate, Weight Loss; Drug · Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 30 Years to 65 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: Stanford, California

Conditions: Overweight, Eating Disorders
Interventions: Emotion regulation group therapy, Orlistat/alli program; Behavioral · Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Stanford, California

Conditions: Diabetes Mellitus, Type 2, PreDiabetes
Interventions: Dietary intervention; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Depression, Psychotic Disorders, Depressive Disorder, Major
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 73 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2012
U.S. locations: 1
States / cities: Stanford, California

Conditions: Cell Transplantation
Interventions: Medical Chart Review, Monitoring Device, Physical Therapy; Other · Device · Procedure
Lead sponsor: Stanford University; Other
Eligibility: Not listed
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Palo Alto, California

Search by objective public record fields.

Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors

Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel

Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder

Effect of Ondansetron for Withdrawal Symptoms

Optimizing a Smartphone Application for Individuals With Eating Disorders

Social Motivation Intervention for Children With Autism Spectrum Disorder: Improving Peer Initiation

Autologous Regenerative Technology (ART) For Wound Healing

SEEG-Guided DBS for OCD

Heritability of Opioid Effects: A Twin Study

High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma

Immersive Technology to Improve Physical Therapy Engagement

Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA

Feasibility and Acceptability of the Cannabis Awareness and Prevention Toolkit

Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)

Imaging Synapses With [11C] UCB-J in the Human Brain

Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy

Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT

Characterizing the EEG Signature of Fentanyl and Its Association With Drug Liking

Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy

Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.

Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating Disorder

Prediabetes Stratification by Multi-omics Profile After Food Intake

Clinical and Biological Characteristics of Psychotic Depression

Prescribed Physical Activity in Improving Sleep and Physical Performance in Patients Undergoing Stem Cell Transplant